Particularly for cancer drivers such as MYC, indirect targeting—that is, modulation of genes which are critical for that driver’s effect on cellular signaling but which also can be targeted with small molecules—have yielded several promising results (Chen et al, 2018). Here, MYC is linked to cancer.